Cargando…
Small Molecule Drug Candidates for Managing the Clinical Symptoms of COVID-19: a Narrative Review
Towards the end of 2019, an atypical acute respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified in Wuhan, China and subsequently named Coronavirus disease 2019 (COVID-19). The rapid dissemination of COVID-19 has provoked a global crisis in public...
Autores principales: | Yun, Chawon, Lee, Hyun Jae, Lee, Choong Jae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551738/ https://www.ncbi.nlm.nih.gov/pubmed/34615772 http://dx.doi.org/10.4062/biomolther.2021.134 |
Ejemplares similares
-
Searching for Novel Candidate Small Molecules for Ameliorating Idiopathic Pulmonary Fibrosis: a Narrative Review
por: Kim, Kyung-il, et al.
Publicado: (2023) -
Natural Products as Sources of Novel Drug Candidates for the Pharmacological Management of Osteoarthritis: A Narrative Review
por: Kang, Young-Hoon, et al.
Publicado: (2019) -
Eriodictyol Inhibits the Production and Gene Expression of MUC5AC Mucin via the IκBα-NF-κB p65 Signaling Pathway in Airway Epithelial Cells
por: Yun, Chawon, et al.
Publicado: (2021) -
Recent Advances in the Development of Novel Drug Candidates for Regulating the Secretion of Pulmonary Mucus
por: Li, Xin, et al.
Publicado: (2020) -
Cyclobutanes in Small‐Molecule Drug Candidates
por: van der Kolk, Marnix R., et al.
Publicado: (2022)